Création et Réalisation Company Profile

11:24 EST 22nd November 2017 | BioPortfolio



10-12 Avenue de I'Arche


Phone: 01 46 91 11 29

News Articles [1 Associated News Articles listed on BioPortfolio]

Sparing Vision au sommet du i-LAB 2017

Tous les jours un bref écho des principales infos de la veille avec le remindHIER de BiotechFinances SparingVision, thérapie émergente contre la baisse de vision centrale générée par les rétin...

Drugs and Medications [0 Results]


PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.

The Wnt/β-catenin signalling pathway is pivotal for stem cell function and the control of cellular differentiation, both during embryonic development and tissue homeostasis in adults. Its activity is...

Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.

The poly(ADP-ribose) polymerases (PARPs) catalyze poly(ADP-ribosyl)ation, a post-translational modification of proteins. This  consists of the attachment of mono- or poly-adenosine diphosphate (ADP)-...

Carbon dioxide insufflation and thoracoscopic ultrasonography image of pure ground-glass nodule.

Thoracic surgeons frequently encounter early lung cancer showing a pure ground-glass nodule. Although thoracoscopic wedge resection is used extensively, it cannot be easily located for surgical proced...

Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells.

Imetelstat (GRN163L) is a potent and selective inhibitor of telomerase. We have previously reported that GRN163L could shorten telomeres and limit the lifespan of CD18/HPAF and CAPAN1 pancreatic cance...

A histone-mimicking interdomain linker in a multi-domain protein modulates multivalent histone binding.

N-terminal histone tails are subject to many posttranslational modifications that are recognized by and interact with designated reader domains in histone-binding proteins. BROMO domain adjacent to zi...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

A Study of Taspoglutide in Type 2 Diabetic Patients

This crossover study will assess the effect of 2 doses of Taspoglutide on first- and second-phase insulin secretion in patients with type 2 diabetes. Patients w ill receive a continuous su...

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating EGFR Mutation

This multicenter, randomized, double-blind, placebo-controlled study will evalua te the safety and efficacy of onartuzumab in combination with erlotinib in patie nts with previously untrea...

A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)

This randomized, 3-arm, multicentre, phase III study will evaluate the efficacy and safety of trastuzumab emtansine (T-DM1) with pertuzumab or trastuzumab emtan sine (T-DM1) with pertuzuma...

A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Patients With Advanced Solid Tumors

This open-label, multicenter, dose-escalation study will assess the safety, tole rability, pharmacokinetics and pharmacodynamics of RO5509554 in patients with ad vanced solid tumors which ...

Companies [8 Associated Companies listed on BioPortfolio]

Création et Réalisation


Biotechnologies & Finances

Le nouveau site de Biotechnologies & Finances est sur le point d'être terminé, et la première version définitive devrait voir le jour fin Février. Des mises à jour régulières après minuit ren...

LAPHAL Industries

LAPHAL Industries a connu depuis sa création au début des années 70, différentes étapes dans la recherche de productivité industrielle.Aujourd'hui, son potentiel humain et ses derniers investiss...


Agoranov est un incubateur public qui a pour mission de faciliter la création d'entreprises valorisant les résultats de la recherche. Agoranov reçoit le soutien du ministère de la Recherche, du FS...


Semia can house you in a location tailored to your needs, since Semia is present in many different places, from famous universities to major research institutions in Alsace. Each location is adapted t...

More Information about "Création et Réalisation" on BioPortfolio

We have published hundreds of Création et Réalisation news stories on BioPortfolio along with dozens of Création et Réalisation Clinical Trials and PubMed Articles about Création et Réalisation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Création et Réalisation Companies in our database. You can also find out about relevant Création et Réalisation Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record